HIV-associated sensory neuropathy: down, but not out

2016-09-20T12:24:00Z (GMT) by Peter Kamerman
Files associated with a blog post ( that examined whether the prevalence of HIV-associated sensory neuropathy (HIV-SN), and the presence of pain in those with HIV-SN, differs between patients stratified according to whether they have/have not been exposed to neurotoxic antiretroviral drugs.<div><br></div><div>The analysis used data published in Table 1 and Table 2 of Ellis et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. <i>Arch. Neurol</i>. <b>67</b>: 552–558, 2010. doi: 10.1001/archneurol.2010.76. </div><div><br></div><div>The files include:</div><div>1. A web archive file of blog posting</div><div>2. A markdown document of the blog</div><div>3. The data analysis script (RMarkdown)</div><div>4. Figures generated in the analysis (.svg and .png format)</div><div>5. Tables extracted from Ellis et al. (2010)</div><div><br></div><div>The permalink for the blog posting is: (<i>link below</i>).</div><div><br></div><div>A copy of the analysis scripts is available under the ellis-2010 subdirectory of the second-look-PAIN GitHub repository (; <i>link below</i>).</div><div><br></div>